CARIS LIFE SCIENCES, INC. Advertising Expense
CARIS LIFE SCIENCES, INC. (CAI) reported Advertising Expense of $3.60 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AdvertisingExpense · last filed 2026-03-03
- CARIS LIFE SCIENCES, INC. advertising expense for the quarter ending 2025-12-31 was $3.10M, a 933.33% increase year-over-year.
- CARIS LIFE SCIENCES, INC. advertising expense for the quarter ending 2025-09-30 was $300.00K, a 25.00% decline year-over-year.
- CARIS LIFE SCIENCES, INC. advertising expense for the quarter ending 2025-06-30 was $100.00K, a 66.67% decline year-over-year.
- CARIS LIFE SCIENCES, INC. advertising expense for the quarter ending 2025-03-31 was $100.00K.
- CARIS LIFE SCIENCES, INC. advertising expense for fiscal 2025 was $3.60M, a 200.00% increase from fiscal 2024.
- CARIS LIFE SCIENCES, INC. advertising expense for fiscal 2024 was $1.20M, a 100.00% increase from fiscal 2023.
- CARIS LIFE SCIENCES, INC. advertising expense for fiscal 2023 was $600.00K.
| Period end | Advertising Expense 3 month | Advertising Expense 6 month | Advertising Expense 9 month | Advertising Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $3.40M derived: sum of 2 quarters · filed 2026-03-03 | $3.50M derived: sum of 3 quarters · filed 2026-03-03 | $3.60M 10-K · filed 2026-03-03 |
| 2025-09-30 | $300.00K 10-Q · filed 2025-11-05 | $400.00K derived: sum of 2 quarters · filed 2025-11-05 | $500.00K 10-Q · filed 2025-11-05 | $800.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2025-06-30 | $100.00K 10-Q · filed 2025-08-12 | $200.00K 10-Q · filed 2025-08-12 | $500.00K derived: sum of 3 quarters · filed 2026-03-03 | $900.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2025-03-31 | $100.00K derived: 10-K 12 month − 3 quarters · filed 2026-03-03 | $400.00K derived: sum of 2 quarters · filed 2026-03-03 | $800.00K derived: sum of 3 quarters · filed 2026-03-03 | $1.10M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $700.00K derived: sum of 2 quarters · filed 2026-03-03 | $1.00M derived: sum of 3 quarters · filed 2026-03-03 | $1.20M 10-K · filed 2026-03-03 |
| 2024-09-30 | $400.00K 10-Q · filed 2025-11-05 | $700.00K derived: sum of 2 quarters · filed 2025-11-05 | $900.00K 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $300.00K 10-Q · filed 2025-08-12 | $600.00K 10-Q · filed 2025-08-12 | ||
| 2023-12-31 | $600.00K 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |